Angiogenesis inhibition: The next frontier in multimodal therapy for glioblastoma multiforme: Commentary

Rohit R. Sharma; Ralph R. Weichselbaum

doi:10.1038/ncponc0879

Angiogenesis inhibition: The next frontier in multimodal therapy for glioblastoma multiforme: Commentary

Rohit R. Sharma, Ralph R. Weichselbaum

Research output: Contribution to journal › Short survey › peer-review

Original language	English (US)
Pages (from-to)	454-455
Number of pages	2
Journal	Nature Clinical Practice Oncology
Volume	4
Issue number	8
DOIs	https://doi.org/10.1038/ncponc0879
State	Published - Aug 2007

ASJC Scopus subject areas

Oncology

Access to Document

10.1038/ncponc0879

Cite this

@article{7d9f3e2f1a954a3c8dfc5a194758064b,

title = "Angiogenesis inhibition: The next frontier in multimodal therapy for glioblastoma multiforme: Commentary",

author = "Sharma, {Rohit R.} and Weichselbaum, {Ralph R.}",

year = "2007",

month = aug,

doi = "10.1038/ncponc0879",

language = "English (US)",

volume = "4",

pages = "454--455",

journal = "Nature Clinical Practice Oncology",

issn = "1743-4254",

publisher = "Nature Publishing Group",

number = "8",

}

TY - JOUR

T1 - Angiogenesis inhibition

T2 - The next frontier in multimodal therapy for glioblastoma multiforme: Commentary

AU - Sharma, Rohit R.

AU - Weichselbaum, Ralph R.

PY - 2007/8

Y1 - 2007/8

UR - http://www.scopus.com/inward/record.url?scp=34548572483&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34548572483&partnerID=8YFLogxK

U2 - 10.1038/ncponc0879

DO - 10.1038/ncponc0879

M3 - Short survey

C2 - 17609654

AN - SCOPUS:34548572483

SN - 1743-4254

VL - 4

SP - 454

EP - 455

JO - Nature Clinical Practice Oncology

JF - Nature Clinical Practice Oncology

IS - 8

ER -

Angiogenesis inhibition: The next frontier in multimodal therapy for glioblastoma multiforme: Commentary

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this